Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Aug 25 2020

Full Issue

Pharma Asks: Where Is Trump's Drug Price Order?

The Trump administration has still not released the president's executive order said to tie some U.S. drug prices to European drug prices. In other news: a disconnect on pill change alerts, and a unit of Sun Pharma settles allegations.

The New York Times: Trump Keeps Promoting A Drug Order That No One Has Seen 

President Trump has made his executive order tying prescription drug prices in the United States to the prices paid in Europe and other developed nations — and the ensuing war that has broken out with the pharmaceutical industry — a centerpiece of his campaign for re-election. The problem: No such executive order has been released. (Gay Stolberg and Sanger-Katz, 8/24)

Stat: Pharmacists Say They Tell Patients About Pill Changes, But Patients Say Otherwise

Most consumers say they aren’t notified of physical changes in their prescription pills, even though most pharmacists report they do alert their customers, a disconnect that is contributing to a lack of patient adherence, according to a new analysis. At issue are the occasional variations in shape, size, or color of medicines that manufacturers make for different reasons. Half of 1,000 consumers who were surveyed reported such a change in the past year, and 29% thought they received the wrong pill. As a result, 1 in 8 either took their pills less frequently or stopped taking them altogether. (Silverman, 8/24)

Stat: Sun Pharma Unit To Pay $21M For Giving False Instructions For Acne Treatmnt

A unit of Sun Pharmaceuticals agreed to pay nearly $21 million to settle allegations of providing false instructions to doctors for an acne treatment and, in turn, causing federal health care programs such as Medicare to overpay for the medication.At issue is a product called Levulan Kerastick, an acne ointment that is used in conjunction with an illuminated blue light. (Silverman, 8/24)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF